U.S. Consumer Services Stock News

U.S. federal appellate court rules that Ardelyx’s Xphozah will be included in Medicare’s ESRD bundled payment system, ending separate reimbursement. The decision resolves a long-running legal dispute over how the drug is treated under Medicare’s payment structure for dialysis care. The ruling affects how dialysis providers are paid for Xphozah and may influence pricing decisions and product positioning for NasdaqGM:ARDX. Ardelyx, the biopharmaceutical company behind Xphozah, focuses on...

AI infrastructure has shifted from a niche theme to a major force in markets, as investors respond to headlines about Micron, Intel, AMD and other chip stocks adding trillions in combined market value. Instead of chasing every hype cycle, it can help to focus on companies with solid financial and market metrics that are directly exposed to this AI infrastructure build out. This article walks through 3 stocks from our AI Infrastructure Beneficiaries screener that appear positively exposed to...

In late June 2026, Olema Pharmaceuticals, Inc. (NasdaqGS:OLMA) was added to multiple Russell Growth Benchmarks, including the Russell 2000, 2500, 3000, 3000E, Small Cap Comp, and Microcap Growth indices. This broad index inclusion brings Olema onto the radar of a wide range of index-tracking funds and quantitative investors, potentially changing how the company is positioned in many portfolios. Next, we will examine how Olema’s broad Russell Growth index inclusion shapes its investment...

With UK GDP slipping 0.1% in April and inflation risks back in focus, many investors are rethinking how much economic stress their portfolios can handle. Consumer staples stocks, which sell everyday essentials, can sometimes offer a steadier ride when growth cools and headlines turn harsher. This article looks at how the latest UK data, conflict in Iran and Bank of England inflation warnings could affect large, defensive companies in this space. Ahead, you will see 3 stocks from our Consumer...

In the past week, Concentrix Corporation reported second-quarter 2026 results showing revenue of US$2,462.47 million and net income of US$55.28 million, alongside updated guidance that points to minimal constant-currency revenue growth for the third quarter and full fiscal year. Despite meeting revenue expectations and achieving record iX Suite contract signings with very large year-on-year growth, Concentrix reduced its full-year outlook while affirming its dividend and completing a...

Why Vor Biopharma’s index additions matter for investors Vor Biopharma (VOR) has just been added to a wide range of Russell indexes, including the Russell 2000 and Russell 3000 families, drawing fresh attention from investors and index tracking funds. This kind of broad index inclusion often prompts passive institutional buying activity, which can influence liquidity and trading volumes in the stock. For you as an investor, the key questions are how meaningful this index presence might be and...

With Janet Yellen urging more disciplined fiscal policy, the Federal Reserve hinting at a pause in rate hikes, and inflation data easing some of the pressure on monetary policy, growth stocks are back in focus for investors weighing risk and reward. The current mix of cautious optimism and uncertainty can reward companies that already have solid revenue trends and sensible reinvestment plans. This article looks at three growth stocks from our screener that appear closely tied to these policy...

Spire Inc. recently reported strong adjusted earnings and raised its full-year guidance, citing continued benefits from its natural gas infrastructure investments. This combination of improved results and a higher earnings outlook underscores the resilience of Spire’s regulated utility model and cash-flow profile. Next, we’ll examine how Spire’s upgraded full-year guidance feeds into its existing investment narrative around regulated expansion and earnings stability. Explore 26 top quantum...

From what we can see, insiders were net sellers in Innventure, Inc.'s ( NASDAQ:INV ) during the past 12 months. That...

Rocket Lab has announced an agreement to acquire satellite communications company Iridium, creating a new vertically integrated player in the sector. The deal brings together launch services and Iridium's established low Earth orbit network, reshaping the competitive field that includes Viasat (NasdaqGS:VSAT). This transaction has not been widely discussed in relation to Viasat, even though it could influence how investors think about different satellite business models. Viasat, traded as...

Federal student loan rules are shifting again, and this time the changes reach deep into graduate and professional programs. Higher annual borrowing caps and a wider range of eligible degrees could alter how money flows into universities, education services and student lending businesses. That creates fresh angles for both opportunity and risk as funding access reshapes demand. This article looks at 3 stocks from our Higher Education and Student Lending Stocks screener that appear especially...

Webull (BULL) has caught investor attention after recent trading, with the stock closing at $6.75 and short term returns mixed, up about 5% over the past month but down year to date. See our latest analysis for Webull. While Webull’s share price return over the past 90 days is up 40.62%, the year to date share price return is down 17.58% and the 1 year total shareholder return is down 43.56%. This suggests that recent momentum contrasts with weaker longer term performance. If you are weighing...

WisdomTree (NYSE:WT) has expanded its international ETF lineup with a new Asia Defense fund that excludes China. The fund targets companies tied to defense spending and related themes in Japan, South Korea, and India. The expansion also highlights a focus on tactical themes such as semiconductors and regional security supply chains. For investors watching ETF providers move beyond U.S. mega-caps, WisdomTree is leaning into global and sector-focused products. The new Asia Defense fund sits...

If you are wondering whether Casey's General Stores stock still offers value after a strong run, you are not alone in asking what a fair price looks like today. The share price recently closed at US$780.24, with returns of 40.3% year to date and 53.4% over the past year, even after a 6.2% decline in the last week and a modest 1.7% gain over the past month. Recent news coverage has focused on Casey's General Stores as investors look for context behind this very large 3 year return of 225.6%...

On 27 June 2026, Globalstar, Inc. was dropped from the Russell 2000 family of indices and simultaneously added to the Russell 1000, Russell Midcap, and related growth and dynamic benchmarks, marking a shift in its classification within the Russell index universe. This reclassification alters how many index-tracking and quantitative funds may hold Globalstar, potentially reshaping its shareholder base and trading patterns over time. Next, we will examine how Globalstar’s move into larger-cap...

The market remained flat over the last week, but over the past 12 months, it has risen by 20%, with earnings expected to grow by 19% per annum in the coming years. In this environment, identifying high growth tech stocks involves looking for companies that demonstrate strong innovation and adaptability to capitalize on these positive market trends.

If you are wondering whether EMCOR Group at around US$814 a share is still offering good value or has run too far ahead, this article walks through the numbers in a clear, practical way. The stock has had a mixed short term pattern, with the share price down 6.3% over the past week and down 1.5% over the past month, while still showing a 27.5% gain year to date and a 52.5% return over the last year. Recent coverage has focused on EMCOR Group's position within the construction and capital...

In the last week, the United States market has stayed flat, but it is up 20% over the past year with earnings expected to grow by 19% annually in the coming years. In this environment, identifying undervalued stocks—those trading below their intrinsic value—can offer potential opportunities for investors seeking to capitalize on future growth prospects.

In the last week, the market has stayed flat, but it is up 20% over the past year with earnings forecast to grow by 19% annually. While penny stocks may seem like a relic from past market eras, they continue to offer unique opportunities for growth, particularly in smaller or newer companies. When these stocks are backed by strong financial health and solid fundamentals, they can present an attractive mix of affordability and potential upside.

The United States market remained flat over the last week but has experienced a significant 20% increase over the past year, with earnings expected to grow by 19% annually. In this context, growth companies with high insider ownership can be particularly appealing as they often indicate strong internal confidence and alignment of interests between management and shareholders.

Over the last 7 days, the United States market has remained flat, yet it has shown a robust 20% increase over the past year. In this context of steady growth and promising earnings projections, dividend stocks like Euroseas can offer investors a reliable income stream while potentially benefiting from capital appreciation.

Niagen Bioscience (NAGE) has been drawing attention after its recent rebranding from ChromaDex Corporation, shifting investor focus toward its healthy aging product portfolio and proprietary NIAGEN ingredient as the stock reacts to this corporate transition. See our latest analysis for Niagen Bioscience. Recent trading has been weaker for Niagen Bioscience, with the share price at about US$3.30 after declining around 15% over the past month and about 47% year to date. The 3 year total...

The Supreme Court’s decision to uphold birthright citizenship removes a major source of uncertainty for millions of families and the employers that rely on them. For investors, clearer immigration rules can mean steadier labor supply and more predictable consumer demand, which can matter as much as any earnings report. This article looks at three stocks exposed to this ruling through their dependence on immigrant workers or diverse customer bases. Each one could see business conditions shaped...

Index additions put Custom Truck One Source in focus Custom Truck One Source (CTOS) has attracted fresh attention after being added to several Russell growth indices, including the Russell 2000 Growth, 2500 Growth, 3000 Growth, 3000E Growth, and Small Cap Comp Growth benchmarks. See our latest analysis for Custom Truck One Source. Custom Truck One Source has already seen strong share price momentum, with a 30 day share price return of 24.7%, a 90 day return of 81.9% and a year to date gain of...